...NF1-, and 23.8% as Triple-WT. In-silico prediction identified a potential new candidate driver, CBL, in 10.4% of the pat...
...NF1) patients. In the context of NF1, MPSNTs develop from benign premalignant precursors. The transition to malignancy i...
...NF1) is normally avoided, since these children are at an elevated risk of developing severe sequelae. NF1 patients are m...
...NF1-18Sr2b (NF1) is the standard and widely used primer pair to assess nematode communities. However, this primer also p...
...NF1, RB1, and TP53 mutations, plus increased AKT2 gene copy number. First-line platinum-based chemotherapy combined with...
...NF1, and CHEK2) and deciphered the functional consequences leveraging the higher throughput Illumina NovaSeq X and NextS...
...Nf1, Gnas and Trp53 (murine ortholog of the human TP53 gene), a splice-site mutation in Crebbp and truncating variants i...
...NF1, PRKACB, PAM, and CHEK2. Given the potential for gene-specific therapeutic implications in these diseases, multimoda...
...NF1 was seen in 2 cases, including 1 in a patient with neurofibromatosis type 1. Three patients showed possible evidence...
...NF1) or type 2 (NF2) stigmata. Malignant transformation is rare but documented. We report a 44-year-old patient with mul...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
